Home ›
Leukemia Trials ›
NCT06904482
Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood
The purpose of this study is to see if see if adding the specific combination of donors can result in acceptable levels of survival without evidence of disease.
Trial Details
NCT ID NCT06904482
Phase PHASE2
Sponsor Case Comprehensive Cancer Center
Status RECRUITING
Cancer Type Leukemia
Interventions Haplo-Identical / Cord Blood Transplant
Locations (sample) Cleveland, Ohio, United States|41.4995,-81.69541
Key Eligibility Criteria
Participants with the following hematologic malignancies: Acute myelogenous leukemia (AML): High-risk AML including: Antecedent hematological disease (e.g., myelodysplasia (MDS)) Treatment-related
For full eligibility, visit ClinicalTrials.gov .
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Leukemia Trials on Trialify →